GO:0099012 neuronal dense core vesicle membrane: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0099012 (neuronal dense core vesicle membrane) is the lipid bilayer that surrounds a neuronal dense core vesicle (DCV), the organelle that stores and releases neuropeptides and monoamines in neurons.
• DCV membrane docking and fusion depend on core machinery including Munc18-1, CAPS, syntaxin and Vti proteins, which are conserved regulators of regulated secretion.
• The DCV membrane is a dynamic platform whose protein and lipid composition is remodeled during biogenesis, transport, docking and fusion, with myosin Va contributing to biogenesis and function.
• Loss of DCV membrane machinery causes neurodevelopmental and neurological disease, exemplified by EIPR1 variants that impair endolysosomal and dense core vesicle function.
• Quantitative assays in rodent CNS neurons allow measurement of DCV fusion capacity, pool replenishment and release kinetics, providing functional readouts for the membrane.
• O-glycoproteome mapping has revealed driver functions in the regulated secretory pathway, linking glycosylation-dependent trafficking to DCV membrane biology.
Description
Neuronal dense core vesicles (DCVs) are specialized secretory organelles that store and release neuropeptides, growth factors and monoamines, and the membrane that encloses them is annotated as GO:0099012, neuronal dense core vesicle membrane. This membrane is not a passive container: it carries the machinery that mediates docking, priming and Ca2+-triggered fusion with the plasma membrane, and its composition determines the efficiency of regulated secretion in the nervous system. Because DCV cargoes modulate synaptic strength, circuit activity and long-range neuromodulation, the DCV membrane is a focal point for understanding how neurons control chemical signaling. From a cell-biological perspective, the neuronal dense core vesicle membrane is the lipid bilayer surrounding a DCV, and it is functionally defined by the proteins that associate with it during vesicle biogenesis, transport and exocytosis. Key regulators include Munc18-1, which promotes large dense-core vesicle docking, and CAPS, which together with syntaxin docks DCVs to the plasma membrane in neurons. Additional layers of control are provided by Vti proteins, which act beyond endolysosomal trafficking, and by myosin Va, which has versatile roles in DCV biogenesis and function. For researchers, GO:0099012 provides a precise annotation target for imaging, proteomic and genetic studies of regulated secretion. Quantitative protocols now permit analysis of DCV fusion in rodent CNS neurons, and hippocampal neurons can be used to measure maximal fusion capacity and efficient replenishment of the DCV pool. Human genetics has further underscored the importance of this membrane system: EIPR1 variants cause a neurodevelopmental disorder with endolysosomal and dense core vesicle defects, directly connecting DCV membrane biology to disease. Mapping of the neuronal O-glycoproteome has also identified driver functions in the regulated secretory pathway, expanding the set of candidate regulators that may localize to or act upon the DCV membrane.
neuronal dense core vesicle membrane At A Glance
| GO ID | GO:0099012 |
|---|---|
| GO term | neuronal dense core vesicle membrane |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Lipid bilayer surrounding a neuronal dense core vesicle; platform for docking, priming and fusion machinery |
| Associated machinery | Munc18-1, CAPS, syntaxin, Vti proteins, myosin Va |
| Related disease | Neurodevelopmental disorder with endolysosomal and dense core vesicle defects (EIPR1 variants) |
| Experimental readouts | DCV fusion assays in rodent CNS neurons; hippocampal DCV pool replenishment |
| Pathway context | Regulated secretory pathway; O-glycoproteome drivers |
What Is GO:0099012?
GO:0099012, neuronal dense core vesicle membrane, is defined in QuickGO as the lipid bilayer surrounding a neuronal dense core vesicle. In practical terms, it is the membrane boundary of a neuronal DCV, the organelle in which neuropeptides and other regulated secretory cargoes are stored before Ca2+-dependent release. The term is a cellular component annotation and refers specifically to the bilayer itself rather than to the vesicle lumen or to the plasma membrane with which the DCV fuses.
Why Is neuronal dense core vesicle membrane Important in Cell Biology?
The neuronal dense core vesicle membrane is important because it is the physical interface through which neurons convert stored neuropeptides and monoamines into secreted signals. Docking and fusion of DCVs require membrane-associated factors such as Munc18-1 and CAPS/syntaxin, so the composition and integrity of the DCV membrane directly set the gain of regulated secretion. Disruption of this membrane system has clinical consequences, as shown by EIPR1 variants that cause a neurodevelopmental disorder with endolysosomal and dense core vesicle defects. Moreover, the DCV membrane is remodeled during biogenesis and transport by factors such as myosin Va and Vti proteins, making it a dynamic hub rather than a static boundary. Quantitative measurements of DCV fusion capacity and pool replenishment in hippocampal neurons provide functional evidence that membrane-level changes alter secretion. Finally, O-glycoproteome analyses have identified regulated secretory pathway drivers, suggesting that post-translational modifications influence DCV membrane trafficking.
• Defines the organelle boundary that separates stored neuropeptides from the cytosol and controls their regulated release.
• Hosts docking and fusion machinery including Munc18-1, CAPS and syntaxin, which are required for DCV exocytosis.
• Is remodeled during DCV biogenesis and transport, with myosin Va playing versatile roles in biogenesis and function.
• Is linked to human neurodevelopmental disease through EIPR1 variants that impair endolysosomal and dense core vesicle function.
• Can be studied quantitatively in rodent CNS neurons using DCV fusion assays and hippocampal pool replenishment measurements.
• Is influenced by the regulated secretory pathway and O-glycoproteome drivers, connecting glycosylation to DCV membrane biology.
• Provides a cellular component annotation for interpreting proteomic and imaging datasets of neuronal secretion.
• Serves as a target for genetic models that test causality of candidate genes in regulated secretion.
• Helps distinguish DCV membrane defects from plasma membrane or synaptic vesicle defects in disease models.
• Supports cross-species comparison because Vti proteins and CAPS/syntaxin mechanisms are conserved.
Structure, Assembly and Molecular Mechanism of neuronal dense core vesicle membrane
What Happens During neuronal dense core vesicle membrane biogenesis?
In simple terms: The DCV membrane is built and loaded with cargo as the vesicle forms inside the neuron.
Neuronal dense core vesicles acquire their membrane during biogenesis at the trans-Golgi network and related compartments, and this process is influenced by myosin Va, which has versatile roles in DCV biogenesis and function. Vti proteins act beyond endolysosomal trafficking and contribute to the membrane trafficking steps that generate and mature DCVs. The resulting bilayer, annotated as GO:0099012, surrounds the DCV and defines its identity as a regulated secretory organelle.
What Happens During neuronal dense core vesicle membrane docking?
In simple terms: The vesicle membrane is captured at the plasma membrane so the vesicle is ready to release its cargo.
Docking of large dense-core vesicles requires Munc18-1, which promotes vesicle docking, and CAPS, which together with syntaxin docks dense core vesicles to the plasma membrane in neurons. These events occur at the DCV membrane and involve interactions between vesicle membrane proteins and plasma membrane partners. Loss of these factors impairs the positioning of DCVs prior to fusion.
What Happens During neuronal dense core vesicle membrane fusion?
In simple terms: The vesicle membrane merges with the plasma membrane to release neuropeptides outside the cell.
Ca2+-triggered fusion of the DCV membrane with the plasma membrane releases stored cargo, and this process can be measured quantitatively in rodent CNS neurons. Hippocampal neurons display a maximal fusion capacity and efficient replenishment of the DCV pool, indicating that the membrane system supports repeated rounds of release. The fusion step is the functional endpoint of the docking machinery described for Munc18-1 and CAPS/syntaxin.
Structure and Composition of neuronal dense core vesicle membrane
In simple terms: The DCV membrane is a lipid bilayer with embedded and attached proteins that carry out its functions.
The neuronal dense core vesicle membrane is the lipid bilayer surrounding a neuronal dense core vesicle, as defined for GO:0099012. Its protein composition includes trafficking and fusion regulators such as Vti proteins, Munc18-1, CAPS and syntaxin, which associate with or act at the vesicle membrane during docking and fusion. Myosin Va also contributes to DCV membrane-related biogenesis and function, linking the membrane to cytoskeletal transport. O-glycoproteome mapping has identified driver functions in the regulated secretory pathway, suggesting that glycosylated proteins may influence DCV membrane trafficking.
Molecular Mechanism of neuronal dense core vesicle membrane
In simple terms: Specific proteins on the vesicle membrane interact with partners on the plasma membrane to control when cargo is released.
At the molecular level, Munc18-1 promotes large dense-core vesicle docking, and CAPS with syntaxin mediates docking to the plasma membrane in neurons. These interactions are conserved features of regulated secretion and are required for efficient fusion. The DCV membrane is therefore a regulated platform whose molecular state determines fusion competence, and this can be assayed using quantitative DCV fusion protocols in rodent CNS neurons. Vti proteins and myosin Va add additional layers of membrane trafficking control during biogenesis and function.
Regulation of neuronal dense core vesicle membrane function
In simple terms: The activity of the DCV membrane is tuned by trafficking and secretory pathway regulators.
Regulation of DCV membrane function is exerted through the docking and fusion machinery, including Munc18-1 and CAPS/syntaxin, whose activity determines whether vesicles reach and fuse with the plasma membrane. Vti proteins contribute to membrane trafficking steps beyond endolysosomal pathways, and myosin Va influences DCV biogenesis and function. The regulated secretory pathway, including O-glycoproteome drivers, further modulates how DCV membrane cargoes are processed and released. Functional regulation can be quantified by measuring DCV fusion capacity and pool replenishment in hippocampal neurons.
Key Genes Involved in GO:0099012 neuronal dense core vesicle membrane
The following genes and proteins are experimentally implicated in neuronal dense core vesicle membrane biology, docking, fusion or related regulated secretory pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STXBP1 (Munc18-1) | Promotes large dense-core vesicle docking | Core docking factor for DCV membrane studies |
| CADPS (CAPS) | Docks dense core vesicles to the plasma membrane with syntaxin | Essential for DCV docking assays |
| STX1A (syntaxin) | Partners with CAPS to dock dense core vesicles | Plasma membrane target of DCV membrane docking |
| VTI1A/VTI1B | Vti proteins act beyond endolysosomal trafficking | Membrane trafficking regulators relevant to DCV biogenesis |
| MYO5A (myosin Va) | Versatile roles in dense core vesicle biogenesis and function | Links DCV membrane to cytoskeletal transport |
| EIPR1 | Endolysosomal and dense core vesicle function; variants cause neurodevelopmental disorder | Human disease gene for DCV membrane defects |
| DCV cargo markers | Stored neuropeptides and monoamines released by DCV fusion | Readouts for DCV fusion assays |
| Hippocampal DCV pool regulators | Support maximal fusion capacity and pool replenishment | Functional readout of DCV membrane recycling |
| O-glycoproteome drivers | Driver functions in the regulated secretory pathway | Candidate regulators of DCV membrane trafficking |
| SNARE complex components | Mediate membrane fusion downstream of docking | Mechanistic targets for fusion studies |
| Munc18-1 interactors | Modulate docking efficiency | Candidate modifiers of DCV membrane function |
| CAPS interactors | Modulate docking with syntaxin | Candidate modifiers of DCV membrane function |
| Myosin Va cargo adaptors | Support DCV biogenesis and transport | Candidate regulators of DCV membrane dynamics |
| Vti-associated trafficking factors | Regulate membrane trafficking steps | Candidate regulators of DCV membrane trafficking |
| EIPR1 pathway components | Endolysosomal and DCV function | Disease-relevant DCV membrane candidates |
| Regulated secretory pathway glycoproteins | O-glycosylation-dependent driver functions | Candidate modifiers of DCV membrane secretion |
How Is neuronal dense core vesicle membrane Regulated?
Regulation of neuronal dense core vesicle membrane function is mediated by the docking and fusion machinery, including Munc18-1 and CAPS/syntaxin, which control whether DCVs reach and fuse with the plasma membrane. Vti proteins contribute to membrane trafficking steps beyond endolysosomal pathways, and myosin Va influences DCV biogenesis and function. The regulated secretory pathway, including O-glycoproteome drivers, further modulates DCV membrane cargo processing and release. Functional regulation can be quantified by measuring DCV fusion capacity and pool replenishment in hippocampal neurons.
neuronal dense core vesicle membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIPR1 | Neurodevelopmental disorder with endolysosomal and dense core vesicle defects | Knockout or point-mutation iPSC-derived neurons |
| STXBP1 (Munc18-1) | Impaired large dense-core vesicle docking | Knockout neuronal cultures with DCV docking assays |
| CADPS (CAPS) | Defective dense core vesicle docking to plasma membrane | Knockout neurons with syntaxin co-staining |
| MYO5A (myosin Va) | DCV biogenesis and function defects | Knockout or tagged knock-in for live imaging |
| VTI1A/VTI1B | Membrane trafficking defects beyond endolysosomes | Knockout cells with trafficking reporters |
Neurodevelopmental disorders with DCV membrane defects
EIPR1 variants cause a neurodevelopmental disorder with endolysosomal and dense core vesicle defects, directly linking the DCV membrane system to human disease. This finding establishes that disruption of DCV membrane-related trafficking can produce neurological phenotypes and provides a genetic entry point for mechanistic studies. Because DCV membrane docking depends on Munc18-1 and CAPS/syntaxin, defects in these steps are plausible contributors to regulated secretion failure in neurons.
Synaptic and circuit dysfunction
DCV membrane fusion releases neuropeptides that modulate synaptic strength and circuit activity, so impaired fusion capacity or pool replenishment can alter neuronal communication. Quantitative assays in hippocampal neurons show that the DCV pool can be efficiently replenished, and failure of this process would be expected to reduce sustained neuropeptide release. Docking factors such as Munc18-1 and CAPS/syntaxin are required for the membrane fusion steps that underlie these effects.
Endolysosomal and trafficking-related pathology
Vti proteins act beyond endolysosomal trafficking, and myosin Va has versatile roles in DCV biogenesis and function, indicating that DCV membrane biology intersects with broader endomembrane pathways. EIPR1 variants simultaneously affect endolysosomal and dense core vesicle function, reinforcing the connection between these systems in disease. O-glycoproteome drivers in the regulated secretory pathway may further modify disease risk by altering DCV membrane trafficking.
From neuronal dense core vesicle membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for DCV membrane docking? | Knockout neurons with Munc18-1/CAPS-dependent docking assays |
| Does a disease variant impair DCV fusion capacity? | Point-mutation knock-in neurons with quantitative fusion assays |
| Where does a protein localize on the DCV membrane? | Tagged knock-in with fluorescent imaging |
| Can overexpression rescue DCV pool replenishment? | Overexpression in hippocampal neurons with pool replenishment readouts |
| Which genes modify regulated secretion? | CRISPR library screening in secretory cells followed by DCV assays |
| Does a variant alter endolysosomal and DCV function? | Patient-derived iPSC neurons with EIPR1 variants |
How to Study the neuronal dense core vesicle membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| DCV fusion assay | Number and kinetics of dense-core vesicle fusion events | Comparing genetic conditions in rodent CNS neurons |
| Hippocampal pool replenishment assay | Maximal fusion capacity and DCV pool refilling | Testing sustained release defects |
| Live imaging of tagged DCV proteins | Localization and dynamics of membrane proteins | Studying myosin Va and Vti protein function |
| Co-localization with syntaxin/CAPS | Docking at the plasma membrane | Assessing docking defects in knockout neurons |
| O-glycoproteomics | Glycosylated proteins in the regulated secretory pathway | Nominating DCV membrane regulators |
| Patient iPSC-derived neurons | Endolysosomal and DCV phenotypes | Modeling EIPR1-related neurodevelopmental disorder |
| Munc18-1 docking assay | Large dense-core vesicle docking efficiency | Testing docking factor requirements |
| CRISPR library screening | Candidate gene effects on secretion | Discovery of DCV membrane modulators |
Quantitative DCV fusion assays
Quantitative analysis of dense-core vesicle fusion in rodent CNS neurons provides a standardized way to measure fusion events at the DCV membrane. These protocols allow comparison of fusion efficiency across genetic conditions and can be combined with hippocampal neuron cultures to assess maximal fusion capacity and pool replenishment.
Imaging of DCV membrane docking and transport
Live imaging of DCV membrane-associated proteins, including myosin Va and Vti proteins, can reveal biogenesis and transport dynamics. Tagged knock-in models enable visualization of vesicle membrane behavior in intact neurons. Docking to the plasma membrane can be assessed by co-localization with syntaxin and CAPS.
Proteomic and glycoproteomic profiling
Map of the neuronal O-glycoproteome reveals driver functions in the regulated secretory pathway, offering a proteome-scale view of proteins that may act at or on the DCV membrane. Such datasets can nominate candidate regulators for functional testing in DCV fusion assays. Proteomic profiling complements genetic screens by identifying post-translational modifications relevant to DCV membrane trafficking.
Genetic and disease modeling
Human genetics, exemplified by EIPR1 variants, links DCV membrane dysfunction to neurodevelopmental disease and provides validated disease models. Knockout and point-mutation models of docking factors such as Munc18-1 and CAPS can be used to dissect membrane-level mechanisms. Combining these models with quantitative fusion readouts enables causal testing of candidate genes.
How CRISPR Can Be Used to Study GO:0099012 neuronal dense core vesicle membrane
Knockout
CRISPR knockout of genes such as STXBP1 (Munc18-1), CADPS (CAPS) or MYO5A can test their requirement for DCV membrane docking, biogenesis and fusion. Knockout neurons can be analyzed with quantitative DCV fusion assays to determine whether the DCV membrane system is functionally impaired. Loss-of-function models of EIPR1 can also be used to reproduce endolysosomal and dense core vesicle defects.
Point Mutation
Point-mutation knock-in models allow testing of disease-associated variants in DCV membrane-related genes without confounding effects of complete loss of function. Such models are particularly useful for EIPR1 variants linked to neurodevelopmental disorders with DCV defects. Variants in docking machinery can be evaluated using DCV fusion and docking readouts.
Knock-in
Tagged knock-in of DCV membrane proteins enables live imaging of vesicle biogenesis, transport and docking in neurons. Knock-in reporters for DCV cargo or membrane markers can be combined with hippocampal pool replenishment assays. These models help map where candidate proteins act relative to the DCV membrane.
Overexpression
Overexpression of DCV membrane regulators can test sufficiency for enhanced docking, fusion or pool replenishment in hippocampal neurons. Overexpression combined with quantitative fusion assays can reveal gain-of-function effects on regulated secretion. Candidate drivers from O-glycoproteome studies can be overexpressed to test their impact on the regulated secretory pathway.
How EDITGENE Supports neuronal dense core vesicle membrane Research
Researchers studying neuronal dense core vesicle membrane-related genes often need to determine whether a candidate gene is causally involved in DCV docking, fusion or biogenesis, and CRISPR-based models provide a direct way to test this. By combining knockout, point-mutation, knock-in and overexpression strategies with quantitative DCV assays, it becomes possible to move from correlation to mechanism.
Contact EDITGENE today to design your custom CRISPR model for neuronal dense core vesicle membrane research.
Frequently Asked Questions About neuronal dense core vesicle membrane
What is GO:0099012 neuronal dense core vesicle membrane?
GO:0099012 is the cellular component annotation for the lipid bilayer surrounding a neuronal dense core vesicle, the organelle that stores and releases neuropeptides and monoamines.
What is a neuronal dense core vesicle membrane?
It is the membrane boundary of a neuronal dense core vesicle, and it hosts docking and fusion machinery such as Munc18-1 and CAPS/syntaxin.
What genes are involved in neuronal dense core vesicle membrane function?
Key genes include STXBP1 (Munc18-1), CADPS (CAPS), STX1A (syntaxin), VTI1A/VTI1B, MYO5A and EIPR1.
How is the neuronal dense core vesicle membrane studied?
It is studied with quantitative DCV fusion assays in rodent CNS neurons, hippocampal pool replenishment measurements, live imaging and proteomics.
What diseases are linked to neuronal dense core vesicle membrane defects?
EIPR1 variants cause a neurodevelopmental disorder with endolysosomal and dense core vesicle defects, linking the DCV membrane system to human disease.
Which proteins dock dense core vesicles to the plasma membrane?
Munc18-1 promotes large dense-core vesicle docking, and CAPS together with syntaxin docks dense core vesicles to the plasma membrane in neurons.
What is the role of myosin Va in dense core vesicle membrane biology?
Myosin Va has versatile roles in dense core vesicle biogenesis and function, linking the DCV membrane to cytoskeletal transport.
Can DCV fusion capacity be measured quantitatively?
Yes, quantitative analysis of dense-core vesicle fusion in rodent CNS neurons allows measurement of fusion, and hippocampal neurons show maximal fusion capacity and efficient pool replenishment.
What are Vti proteins and how do they relate to DCV membranes?
Vti proteins act beyond endolysosomal trafficking and contribute to membrane trafficking steps relevant to DCV biogenesis and function.
How does O-glycosylation relate to the regulated secretory pathway?
Map of the neuronal O-glycoproteome reveals driver functions in the regulated secretory pathway, suggesting glycosylation influences DCV membrane trafficking.
Conclusion
GO:0099012, neuronal dense core vesicle membrane, defines the lipid bilayer that surrounds neuronal DCVs and serves as the platform for docking and fusion machinery such as Munc18-1 and CAPS/syntaxin. Its biogenesis and function involve Vti proteins and myosin Va, and its dysfunction is linked to neurodevelopmental disease through EIPR1 variants. Quantitative assays in rodent CNS neurons and hippocampal pool replenishment measurements provide robust functional readouts for this membrane system. For researchers, the DCV membrane is a tractable cellular component for CRISPR-based causal studies, proteomic discovery and disease modeling. Combining knockout, point-mutation, knock-in and overexpression strategies with quantitative secretion assays can clarify how candidate genes act at the neuronal dense core vesicle membrane.
References
- 1. Emperador-Melero J et al.. 2019. Vti Proteins: Beyond Endolysosomal Trafficking.. Neuroscience 420:32-40 PMID: 30471354
- 2. Ghosh S et al.. 2026. EIPR1 variants cause a neurodevelopmental disorder with endolysosomal and dense core vesicle defects.. Brain 149(5):1568-1585 PMID: 41058046
- 3. Voets T et al.. 2001. Munc18-1 promotes large dense-core vesicle docking.. Neuron 31(4):581-91 PMID: 11545717
- 4. Hammarlund M et al.. 2008. CAPS and syntaxin dock dense core vesicles to the plasma membrane in neurons.. J Cell Biol 180(3):483-91 PMID: 18250196
- 5. Moro A et al.. 2021. Quantitative analysis of dense-core vesicle fusion in rodent CNS neurons.. STAR Protoc 2(1):100325 PMID: 33659902
- 6. Baginska U et al.. 2023. Maximal Fusion Capacity and Efficient Replenishment of the Dense Core Vesicle Pool in Hippocampal Neurons.. J Neurosci 43(45):7616-7625 PMID: 37852790
- 7. Kögel T et al.. 2010. Versatile roles for myosin Va in dense core vesicle biogenesis and function.. Biochem Soc Trans 38(Pt 1):199-204 PMID: 20074059
- 8. Madsen TD et al.. 2025. Map of the neuronal O-glycoproteome reveals driver functions in the regulated secretory pathway.. J Biol Chem 301(7):110313 PMID: 40449597
